| Value | ₹116.4 Cr |
|---|
NSE filing, NSE: MARUSHIKA. Summary written from the filing by ALFA Finder's alert engine.
Marushika Technology Ltd: key numbers
- Share price
- ₹120.10
- Market cap
- ₹102.5 Cr
- Revenue (annual)
- ₹116.4 Cr
- Net profit (annual)
- ₹8.95 Cr
- P/E (TTM)
- 11.4×Sector 23.5×
- Promoter holding
- 58.19%
- FII holding
- 5.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marushika Technology Ltd
All →Marushika Technology Results Update
Marushika reported H1 FY27 revenue growth of 71.59% and net profit growth of 126.30% year-on-year. The release shows highlights only, not a full results statement.
Marushika Technology H1 FY27 Results: Net Profit ₹7 Cr, Up 125.8% YoY
Marushika Technology Ltd reported revenue from operations of ₹83.5 Cr (+71.8% YoY) and net profit of ₹7 Cr (+125.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7 Cr · +125.8% YoY
Marushika Technology Other Announcement
Marushika Technology filed a Reg 27(2) non-applicability certificate for corporate governance for the half-year ended September 30, 2026. As an NSE Emerge-listed SME, the corporate governance provisions do not apply to it.
Marushika Technology Annual General Meeting
Marushika Technology Limited held its 16th Annual General Meeting on September 25, 2026. The meeting covered the adoption of financial statements and various board appointments.
Marushika Technology Partnership
Marushika Technology commenced a partnership with Sanare Medical as exclusive distributor of ExoAtlet II. The agreement targets government procurement via GeM across Indian public institutions.
Marushika Technology Other Announcement
Marushika Technology Limited has shifted its registered office to a new location in New Delhi, effective September 14, 2026.
Other results update announcements
All →Multi Commodity Exchange of India Results Update
MCX reported H1FY27 consolidated revenue of ₹1,502 crore, up 100.8% YoY, and PAT of ₹868 crore. Q2FY27 PAT rose 130.8% YoY to ₹455 crore.
Shanti Gold International Results Update
Shanti Gold reported H1 FY27 revenue of Rs. 1,462.3 crore and PAT of Rs. 80.0 crore. Revenue doubled, but Q2 EBITDA margin compressed to 5.7%.
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Fine Organic Industries Results Update
Fine Organic reports Q2 FY27 revenue of ₹729.4 Crore and PAT of ₹152.1 Crore, up 40.1%. Results show strong year-on-year growth across revenue, EBITDA and profit.
Jyoti Structures Results Update
Jyoti Structures reported standalone Q2 FY27 total income up 60.2% to Rs 248.57 crore and PAT of Rs 15.37 crore. The order book stood at Rs 4,219 crore as of September 30, 2026.
Samhi Hotels Results Update
SAMHI Hotels reported unaudited Q2 and H1 FY27 results, with Q2 total income up 15.6% to Rs 3,427 Mn and PAT of Rs 411 Mn. Management highlighted same-store growth and a pipeline of about 1,700 new rooms through FY2031.